Income Statement Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 07/02/2026 am IST			5-day change	1st Jan Change
41.01 ^USD	+0.34%		-6.94%	+39.06%

30/01	Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating	MT
30/01	Mib Outperforms Europe Ahead of S&P, Campari Leads Gains	AN

77ec013779c6e91792bf2b72aefcc.vEectqHGxIbapcAh2kMdpHuHJa-idduTu511OAA3MOA.0gzw5pWT6cjs76hNozJSzQvIT9_JFq_qiOpAXW9uHY7vGO3h7bGXq-vdlQ

Published financial data: MODERNA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	80Cr	1.85TCr	1.93TCr	667.1Cr	310.9Cr
Other Revenues, Total	-	-	-	18Cr	13Cr
Total Revenues	80Cr	1.85TCr	1.93TCr	684.8Cr	323.6Cr
Cost of Goods Sold, Total	137.83Cr	460.8Cr	871.1Cr	953.8Cr	600.7Cr
Gross Profit	-57Cr	1.39TCr	1.06TCr	-269Cr	-277.1Cr
Selling General & Admin Expenses, Total	19Cr	57Cr	113.2Cr	154.9Cr	117.4Cr
Other Operating Expenses, Total	19Cr	57Cr	113.2Cr	154.9Cr	117.4Cr
Operating Income	-76Cr	1.33TCr	942Cr	-423.9Cr	-394.5Cr
Interest Expense, Total	-98.86L	-1.8Cr	-2.9Cr	-3.8Cr	-2.4Cr
Interest And Investment Income	2.47Cr	1.8Cr	20Cr	42Cr	42Cr
Net Interest Expenses	1.48Cr	0	17Cr	38Cr	40Cr
Currency Exchange Gains (Loss)	-	-80L	4.8Cr	-	-
Other Non Operating Income (Expenses)	27.39L	-40L	-4.4Cr	-1.4Cr	-70L
EBT, Excl. Unusual Items	-75Cr	1.33TCr	959.5Cr	-387Cr	-355.1Cr
Gain (Loss) On Sale Of Investments	13.01L	10L	-2Cr	-7.2Cr	-5.6Cr
Gain (Loss) On Sale Of Assets	-2L	-	-	-	-
EBT, Incl. Unusual Items	-74Cr	1.33TCr	957.5Cr	-394.2Cr	-360.7Cr
Income Tax Expense	25.51L	108.3Cr	121.3Cr	77Cr	-4.6Cr
Earnings From Continuing Operations	-75Cr	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr
Net Income to Company	-75Cr	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr
Net Income - (IS)	-75Cr	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-75Cr	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr
Net Income to Common Excl. Extra Items	-75Cr	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr
Per Share Items
Net EPS - Basic	-1.96	30.28	21.22	-12.34	-9.27
Basic EPS - Continuing Operations	-1.96	30.28	21.22	-12.34	-9.27
Basic Weighted Average Shares Outstanding	38Cr	40Cr	39Cr	38Cr	38Cr
Net EPS - Diluted	-1.96	28.29	20.12	-12.34	-9.28
Diluted EPS - Continuing Operations	-1.96	28.29	20.12	-12.34	-9.28
Diluted Weighted Average Shares Outstanding	38Cr	43Cr	42Cr	38Cr	38Cr
Normalized Basic EPS	-1.22	20.6	15.22	-6.33	-5.78
Normalized Diluted EPS	-1.22	19.26	14.42	-6.33	-5.78
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-73Cr	1.35TCr	976.8Cr	-361.8Cr	-375.6Cr
EBITA	-76Cr	1.33TCr	942Cr	-423.9Cr	-394.5Cr
EBIT	-76Cr	1.33TCr	942Cr	-423.9Cr	-394.5Cr
EBITDAR	-70Cr	1.37TCr	998.1Cr	-341.5Cr	-359.8Cr
Total Revenues (As Reported)	80Cr	1.85TCr	1.93TCr	684.8Cr	323.6Cr
Effective Tax Rate - (Ratio)	-0.34	8.15	12.67	-19.58	1.28
Current Domestic Taxes	32T	133.9Cr	173.4Cr	-15Cr	-5.8Cr
Current Foreign Taxes	25.19L	4Cr	5.7Cr	2.4Cr	1.3Cr
Total Current Taxes	25.51L	137.9Cr	179.1Cr	-13Cr	-4.5Cr
Deferred Domestic Taxes	-	-29Cr	-58Cr	90Cr	-
Deferred Foreign Taxes	-	-20L	-20L	50L	-10L
Total Deferred Taxes	-	-30Cr	-58Cr	90Cr	-10L
Normalized Net Income	-47Cr	830.25Cr	599.69Cr	-241.88Cr	-221.94Cr
Interest on Long-Term Debt	98.91L	1.7Cr	2.9Cr	3.8Cr	2.4Cr
Supplemental Operating Expense Items
Advertising Expense	-	-	-	20Cr	15Cr
Selling and Marketing Expenses	-	-	-	20Cr	15Cr
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	137.03Cr	199.1Cr	329.5Cr	484.5Cr	454.3Cr
Net Rental Expense, Total	3.55Cr	17Cr	21Cr	20Cr	16Cr
Imputed Operating Lease Interest Expense	1.5Cr	4.32Cr	4.67Cr	5.05Cr	3.05Cr
Imputed Operating Lease Depreciation	2.05Cr	13Cr	17Cr	15Cr	13Cr
Stock-Based Comp., COGS (Total)	5.62Cr	9Cr	14Cr	19Cr	29Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	3.69Cr	5.2Cr	8.8Cr	11Cr	14Cr
Total Stock-Based Compensation	9.3Cr	14Cr	23Cr	30Cr	43Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	262.38Cr	684.8Cr	320.5Cr	290.7Cr	192.7Cr
Short Term Investments	198.38Cr	387.9Cr	669.7Cr	569.7Cr	509.8Cr
Total Cash And Short Term Investments	460.76Cr	1.07TCr	990.2Cr	860.4Cr	702.5Cr
Accounts Receivable, Total	139.06Cr	317.5Cr	138.5Cr	89Cr	36Cr
Other Receivables	2Cr	12Cr	24Cr	19Cr	23Cr
Notes Receivable	-	-	3.6Cr	-	-
Total Receivables	141.05Cr	329.6Cr	166.4Cr	108.1Cr	59Cr
Inventory	4.65Cr	144.1Cr	116.8Cr	27Cr	12Cr
Prepaid Expenses	1.56Cr	13Cr	22Cr	27Cr	17Cr
Restricted Cash	10.32L	-	-	-	-
Other Current Assets, Total	22Cr	48Cr	48Cr	10Cr	19Cr
Total Current Assets	629.79Cr	1.61TCr	1.34TCr	1.03TCr	809.9Cr
Gross Property Plant And Equipment	51Cr	173.5Cr	279.7Cr	309.1Cr	348.2Cr
Accumulated Depreciation	-12Cr	-35Cr	-66Cr	-43Cr	-53Cr
Net Property Plant And Equipment	39Cr	138.3Cr	213.9Cr	265.8Cr	295.5Cr
Long-term Investments	64Cr	684.3Cr	836Cr	474.3Cr	250.8Cr
Goodwill	-	-	-	5.2Cr	5.2Cr
Other Intangibles, Total	-	-	-	4.4Cr	4Cr
Deferred Tax Assets Long-Term	-	33Cr	98Cr	8.1Cr	-
Other Long-Term Assets, Total	1.29Cr	4.6Cr	95Cr	52Cr	49Cr
Total Assets	733.68Cr	2.47TCr	2.59TCr	1.84TCr	1.41TCr
Liabilities
Accounts Payable, Total	1.84Cr	30Cr	49Cr	52Cr	40Cr
Accrued Expenses, Total	45Cr	147.2Cr	183.3Cr	106.9Cr	90Cr
Current Portion of Leases	3.03Cr	21Cr	20Cr	2.5Cr	3.7Cr
Current Income Taxes Payable	-	88Cr	4.8Cr	6.3Cr	-
Unearned Revenue Current, Total	386.72Cr	625.3Cr	203.8Cr	57Cr	15Cr
Other Current Liabilities	2.09Cr	1.4Cr	32Cr	77Cr	71Cr
Total Current Liabilities	438.88Cr	912.8Cr	492.3Cr	301.5Cr	220.6Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	21Cr	70Cr	100.4Cr	121.8Cr	71Cr
Unearned Revenue Non Current	18Cr	62Cr	67Cr	8.3Cr	5.8Cr
Other Non Current Liabilities	18.53L	7.6Cr	14Cr	26Cr	27Cr
Total Liabilities	477.54Cr	1.05TCr	673.5Cr	457.2Cr	324.1Cr
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	40T	-	-	-	-
Additional Paid In Capital	480.18Cr	421.1Cr	117.3Cr	37Cr	87Cr
Retained Earnings	-224.35Cr	995.8Cr	1.83TCr	1.36TCr	1TCr
Comprehensive Income and Other	30.04L	-2.4Cr	-37Cr	-12Cr	-1Cr
Total Common Equity	256.14Cr	1.41TCr	1.91TCr	1.39TCr	1.09TCr
Total Equity	256.14Cr	1.41TCr	1.91TCr	1.39TCr	1.09TCr
Total Liabilities And Equity	733.68Cr	2.47TCr	2.59TCr	1.84TCr	1.41TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40Cr	40Cr	39Cr	38Cr	39Cr
ECS Total Common Shares Outstanding	40Cr	40Cr	38Cr	38Cr	39Cr
Book Value / Share	6.42	35.1	49.67	36.27	28.24
Tangible Book Value	256.14Cr	1.41TCr	1.91TCr	1.38TCr	1.08TCr
Tangible Book Value Per Share	6.42	35.1	49.67	36.02	28
Total Debt	24Cr	92Cr	120Cr	124.3Cr	75Cr
Net Debt	-437Cr	-1.67TCr	-1.7TCr	-1.2TCr	-877.2Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	90L	80L	-	-
Debt Equivalent Oper. Leases	28Cr	138.4Cr	170.4Cr	162.4Cr	126.4Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	3.62Cr	87Cr	58Cr	16Cr	6.3Cr
Inventories - Work In Process, Total	90.15L	34Cr	20Cr	1.5Cr	2.6Cr
Inventories - Finished Goods, Total	12.9L	23Cr	17Cr	2.4Cr	2.8Cr
Land - (BS)	-	-	1.1Cr	2.2Cr	5.9Cr
Buildings, Total	-	-	-	-	74Cr
Machinery, Total	14Cr	20Cr	34Cr	44Cr	52Cr
Full Time Employees	1.3T	2.7T	3.9T	5.6T	5.8T
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	34Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-75Cr	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr
Depreciation & Amortization - CF	9.35Cr	23Cr	35Cr	62Cr	19Cr
Depreciation & Amortization, Total	9.35Cr	23Cr	35Cr	62Cr	19Cr
(Gain) Loss From Sale Of Asset	2L	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	1.02Cr	5.4Cr	3.1Cr	-2.6Cr	-4.3Cr
Stock-Based Compensation (CF)	9.3Cr	14Cr	23Cr	30Cr	43Cr
Other Operating Activities, Total	-	-32Cr	-53Cr	84Cr	6Cr
Change In Accounts Receivable	-138.52Cr	-178.4Cr	179Cr	49Cr	53Cr
Change In Inventories	-4.65Cr	-139.4Cr	49Cr	75Cr	8.3Cr
Change In Accounts Payable	1.19Cr	20Cr	24Cr	1.3Cr	-6.9Cr
Change in Unearned Revenues	384.23Cr	282.4Cr	-415.7Cr	-206Cr	-44Cr
Change In Income Taxes	-	88Cr	-83Cr	1.5Cr	-
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	15Cr	58Cr	-99Cr	65Cr	-19Cr
Cash from Operations	202.7Cr	1.36TCr	498.1Cr	-311.8Cr	-300.4Cr
Capital Expenditure	-6.74Cr	-28Cr	-40Cr	-71Cr	-105.1Cr
Cash Acquisitions	-	-	-	-8.5Cr	-
Investment in Marketable and Equity Securities, Total	-160.45Cr	-823.9Cr	-473.6Cr	502.1Cr	300Cr
Other Investing Activities, Total	-	-	-4Cr	-2.3Cr	-
Cash from Investing	-167.19Cr	-852.3Cr	-517.6Cr	420.6Cr	194.9Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-62.15L	-14Cr	-18Cr	-27Cr	-1Cr
Total Debt Repaid	-62.15L	-14Cr	-18Cr	-27Cr	-1Cr
Issuance of Common Stock	203.94Cr	12Cr	6.5Cr	4.6Cr	6.6Cr
Repurchase of Common Stock	-	-86Cr	-332.9Cr	-115.3Cr	-
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	203.32Cr	-87Cr	-344.8Cr	-137.7Cr	5.6Cr
Net Change in Cash	238.82Cr	422.4Cr	-364.3Cr	-29Cr	-100Cr
Supplemental Items
Cash Interest Paid	85.28L	1.4Cr	2.5Cr	3.9Cr	2.4Cr
Cash Income Tax Paid (Refund)	6L	48Cr	272.9Cr	-36Cr	20Cr
Levered Free Cash Flow	219.05Cr	929.28Cr	366.84Cr	-238.31Cr	-308.76Cr
Unlevered Free Cash Flow	219.67Cr	930.4Cr	368.65Cr	-235.94Cr	-307.26Cr
Change In Net Working Capital	-255.45Cr	-90Cr	237.5Cr	-7.1Cr	17Cr
Net Debt Issued / Repaid	-62.15L	-14Cr	-18Cr	-27Cr	-1Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-10.69	51.93	23.3	-11.97	-15.14
Return on Total Capital	-23.21	93.06	33.28	-14.96	-18.44
Return On Equity %	-39.99	146.08	50.27	-28.59	-28.77
Return on Common Equity	-39.99	146.08	50.27	-28.59	-28.77
Margin Analysis
Gross Profit Margin %	-71.56	75.05	54.78	-39.28	-85.63
SG&A Margin	23.43	3.07	5.88	22.62	36.28
EBITDA Margin %	-91.1	73.24	50.71	-52.83	-116.07
EBITA Margin %	-94.99	71.98	48.9	-61.9	-121.91
EBIT Margin %	-94.99	71.98	48.9	-61.9	-121.91
Income From Continuing Operations Margin %	-92.99	66.06	43.41	-68.84	-110.04
Net Income Margin %	-92.99	66.06	43.41	-68.84	-110.04
Net Avail. For Common Margin %	-92.99	66.06	43.41	-68.84	-110.04
Normalized Net Income Margin	-58	44.95	31.13	-35.32	-68.58
Levered Free Cash Flow Margin	272.65	50.31	19.04	-34.8	-95.41
Unlevered Free Cash Flow Margin	273.42	50.37	19.14	-34.45	-94.95
Asset Turnover
Asset Turnover	0.18	1.15	0.76	0.31	0.2
Fixed Assets Turnover	2.38	20.87	10.94	2.86	1.15
Receivables Turnover (Average Receivables)	1.15	8.09	8.45	5.86	4.97
Inventory Turnover (Average Inventory)	-	6.19	6.02	13.27	37.66
Short Term Liquidity
Current Ratio	1.43	1.76	2.73	3.42	3.67
Quick Ratio	1.37	1.54	2.34	3.21	3.45
Operating Cash Flow to Current Liabilities	0.46	1.49	1.01	-1.03	-1.36
Days Sales Outstanding (Average Receivables)	317.97	45.11	43.2	62.29	73.58
Days Outstanding Inventory (Average Inventory)	-	58.93	60.67	27.51	9.72
Average Days Payable Outstanding	-	9.73	17.67	21.27	28.58
Cash Conversion Cycle (Average Days)	-	94.32	86.21	68.54	54.71
Long Term Solvency
Total Debt/Equity	9.28	6.48	6.28	8.97	6.85
Total Debt / Total Capital	8.49	6.08	5.9	8.23	6.41
LT Debt/Equity	8.09	4.98	5.25	8.79	6.51
Long-Term Debt / Total Capital	7.41	4.68	4.94	8.07	6.1
Total Liabilities / Total Assets	65.09	42.66	26.05	24.81	22.92
EBIT / Interest Expense	-77.19	738.67	324.83	-111.55	-164.38
EBITDA / Interest Expense	-70.44	761.17	344.17	-89.87	-149.92
(EBITDA - Capex) / Interest Expense	-77.27	745.39	330.38	-108.47	-193.71
Total Debt / EBITDA	-0.34	0.07	0.12	-0.36	-0.21
Net Debt / EBITDA	6.28	-1.22	-1.71	3.53	2.44
Total Debt / (EBITDA - Capex)	-0.31	0.07	0.13	-0.3	-0.16
Net Debt / (EBITDA - Capex)	5.72	-1.24	-1.78	2.92	1.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.23T	2.2T	4.29	-64.45	-52.75
Gross Profit, 1 Yr. Growth %	31.82	-2.51T	-23.88	-125.49	3.01
EBITDA, 1 Yr. Growth %	42.2	-1.95T	-27.79	-137.04	3.81
EBITA, 1 Yr. Growth %	39.84	-1.84T	-29.15	-145	-6.94
EBIT, 1 Yr. Growth %	39.84	-1.84T	-29.15	-145	-6.94
Earnings From Cont. Operations, 1 Yr. Growth %	45.34	-1.73T	-31.47	-156.37	-24.46
Net Income, 1 Yr. Growth %	45.34	-1.73T	-31.47	-156.37	-24.46
Normalized Net Income, 1 Yr. Growth %	44.85	-1.88T	-27.77	-140.33	-8.24
Diluted EPS Before Extra, 1 Yr. Growth %	26.08	-1.54T	-28.88	-161.33	-24.8
Accounts Receivable, 1 Yr. Growth %	25.8T	128.25	-56.38	-35.6	-59.87
Inventory, 1 Yr. Growth %	-	2.97T	-32.41	-76.88	-42.08
Net Property, Plant and Equip., 1 Yr. Growth %	34.45	257.36	54.66	24.26	11.17
Total Assets, 1 Yr. Growth %	361.6	236.23	4.82	-28.74	-23.25
Tangible Book Value, 1 Yr. Growth %	118.02	452.32	35.19	-28.06	-21.43
Common Equity, 1 Yr. Growth %	118.02	452.32	35.19	-27.55	-21.32
Cash From Operations, 1 Yr. Growth %	-541.64	571.93	-63.43	-162.6	-3.66
Capital Expenditures, 1 Yr. Growth %	113.75	317.65	40.84	76.75	48.66
Levered Free Cash Flow, 1 Yr. Growth %	-759.55	324.3	-60.53	-164.95	29.56
Unlevered Free Cash Flow, 1 Yr. Growth %	-769.75	323.6	-60.38	-163.98	30.23
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	143.89	1.65T	389.78	-39.11	-59.01
Gross Profit, 2 Yr. CAGR %	34.24	463.88	328.38	-55.95	-48.76
EBITDA, 2 Yr. CAGR %	37.27	412.52	265.3	-48.28	-37.99
EBITA, 2 Yr. CAGR %	35.89	393.47	251.37	-43.54	-35.29
EBIT, 2 Yr. CAGR %	35.89	393.47	251.37	-43.54	-35.29
Earnings From Cont. Operations, 2 Yr. CAGR %	39.35	387.23	234.58	-37.84	-34.74
Net Income, 2 Yr. CAGR %	39.35	387.23	234.58	-37.84	-34.74
Normalized Net Income, 2 Yr. CAGR %	38.17	407.88	259.12	-46.03	-39.1
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.12	326.82	220.34	-33.95	-32.09
Accounts Receivable, 2 Yr. CAGR %	951.16	2.33T	-0.22	-47	-49.16
Inventory, 2 Yr. CAGR %	-	-	398.51	-60.47	-68.35
Net Property, Plant and Equip., 2 Yr. CAGR %	35.13	119.17	135.1	38.63	17.54
Total Assets, 2 Yr. CAGR %	93.37	293.96	87.73	-13.57	-26.05
Tangible Book Value, 2 Yr. CAGR %	29.38	246.99	173.26	-1.38	-24.82
Common Equity, 2 Yr. CAGR %	29.38	246.99	173.26	-1.03	-24.5
Cash From Operations, 2 Yr. CAGR %	147.51	444.73	56.76	-52.15	-22.34
Capital Expenditures, 2 Yr. CAGR %	-20.14	197.91	142.54	57.78	62.1
Levered Free Cash Flow, 2 Yr. CAGR %	195.06	431.67	29.42	-49.36	-8.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	196.62	431.99	29.55	-49.64	-8.7
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	57.45	415.2	584.74	104.31	-44.04
Gross Profit, 3 Yr. CAGR %	41.1	251.57	189.26	67.25	-41.53
EBITDA, 3 Yr. CAGR %	43.28	226.58	166.69	70.34	-34.76
EBITA, 3 Yr. CAGR %	41.5	218.05	158.4	77.11	-33.3
EBIT, 3 Yr. CAGR %	41.5	218.05	158.4	77.11	-33.3
Earnings From Cont. Operations, 3 Yr. CAGR %	42.92	216.54	153.39	84.79	-33.67
Net Income, 3 Yr. CAGR %	42.92	216.54	153.39	84.79	-33.67
Normalized Net Income, 3 Yr. CAGR %	43.01	224	165.1	73.27	-35.58
Diluted EPS Before Extra, 3 Yr. CAGR %	-22.35	78.74	134.87	84.63	-31.03
Accounts Receivable, 3 Yr. CAGR %	369.73	531.87	536.58	-13.77	-51.69
Inventory, 3 Yr. CAGR %	-	-	-	79.1	-59.24
Net Property, Plant and Equip., 3 Yr. CAGR %	40.68	86.86	95.13	90.09	28.8
Total Assets, 3 Yr. CAGR %	89.13	132.53	153.39	35.93	-16.93
Tangible Book Value, 3 Yr. CAGR %	66.86	109.87	153.43	75.14	-8.58
Common Equity, 3 Yr. CAGR %	66.86	109.87	153.43	75.54	-8.32
Cash From Operations, 3 Yr. CAGR %	82.86	245.28	121.4	15.44	-39.58
Capital Expenditures, 3 Yr. CAGR %	4.92	38.99	132.08	118.26	54.68
Levered Free Cash Flow, 3 Yr. CAGR %	152.69	233.02	123.46	2.85	-30.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	152.98	234.01	123.83	2.41	-30.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	179.44	147.88	119.28	122.01
Gross Profit, 5 Yr. CAGR %	-	142.2	120.02	53.18	44.75
EBITDA, 5 Yr. CAGR %	-	130.34	108.35	56.26	48.79
EBITA, 5 Yr. CAGR %	-	126.35	103.58	59.3	48.52
EBIT, 5 Yr. CAGR %	-	126.35	103.58	59.3	48.52
Earnings From Cont. Operations, 5 Yr. CAGR %	-	124.03	100.84	65.06	47.27
Net Income, 5 Yr. CAGR %	-	124.03	100.84	65.06	47.27
Normalized Net Income, 5 Yr. CAGR %	-	128.6	106.6	58.2	47.13
Diluted EPS Before Extra, 5 Yr. CAGR %	-	49.47	36.9	20.02	42.98
Accounts Receivable, 5 Yr. CAGR %	-	197.94	152.79	134.48	131.63
Net Property, Plant and Equip., 5 Yr. CAGR %	-	76.3	72.75	65.83	59.32
Total Assets, 5 Yr. CAGR %	-	77.07	88.57	56.51	54.83
Tangible Book Value, 5 Yr. CAGR %	-	111.43	103.25	55.15	55.87
Common Equity, 5 Yr. CAGR %	-	111.43	103.25	55.37	56.13
Cash From Operations, 5 Yr. CAGR %	-	189.71	71.94	56.62	45.61
Capital Expenditures, 5 Yr. CAGR %	-	53.67	46.94	46.22	101.04
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	93.35	56.78	56.51
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	93.56	56.71	56.36